Michael Schmelmer
Director Ejecutivo en Boehringer Ingelheim Verwaltungs GmbH .
Origen de la red de primer grado Michael Schmelmer.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.
5
| Private Company | Pharmaceuticals: Major | 5 |
Anasco GmbH /DE/
Anasco GmbH /DE/ Financial ConglomeratesFinance Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer.
1
| Subsidiary | Financial Conglomerates | 1 |
BIOTHERAX biochemisch-pharmazeutische GmbH
BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck.
1
| Private Company | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michael Schmelmer a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
MUNICH RE | Life/Health Insurance | Director/Board Member | |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
KWS SAAT SE & CO. KGAA | Miscellaneous Commercial Services | Director/Board Member | |
BIOMÉRIEUX | Medical Specialties | Sales & Marketing | |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Okairos AG
Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Biotechnology | Chief Executive Officer | |
Boehringer Ingelheim AB
Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim RCV GmbH & Co. KG
Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member Director/Board Member | |
Profunda Verwaltungs GmbH
Profunda Verwaltungs GmbH Investment ManagersFinance Part of Profunda Verwaltungs GmbH & Co. KG, the German company provides asset management services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Hubertus von Baumbach, Christoph Gauger. | Investment Managers | Chief Executive Officer | |
Boehringer Ingelheim Europe GmbH
Boehringer Ingelheim Europe GmbH Pharmaceuticals: MajorHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Europe GmbH is a German company that manufactures basic pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler and Martin Schwarz. The company was founded in 1990. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | President | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Institut de Pharmacie Industrielle de Lyon | College/University | Graduate Degree | |
Janssen Therapeutics, Inc. | President | ||
Boehringer Ingelheim Corporate Center GmbH
Boehringer Ingelheim Corporate Center GmbH Real Estate DevelopmentFinance Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties. | Real Estate Development | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
Boehringer Ingelheim Verwaltungs GmbH
Boehringer Ingelheim Verwaltungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007. | Financial Conglomerates | Chief Executive Officer | |
Boehringer Ingelheim Deutschland GmbH
Boehringer Ingelheim Deutschland GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Deutschland GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Beck and Sabine Nikolaus. | Financial Conglomerates | Chief Executive Officer | |
Boehringer Ingelheim Animal Health Japan Holding GmbH
Boehringer Ingelheim Animal Health Japan Holding GmbH Pharmaceuticals: MajorHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health Japan Holding GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Frank Hübler, Martin Schwarz. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim Animal Health China Participations GmbH
Boehringer Ingelheim Animal Health China Participations GmbH Agricultural Commodities/MillingProcess Industries Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health China Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler, Martin Schwarz. The German company was founded in 2019. | Agricultural Commodities/Milling | Chief Executive Officer | |
Merial Participations GmbH
Merial Participations GmbH Agricultural Commodities/MillingProcess Industries Part of C.H. Boehringer Sohn AG & Co. KG, Merial Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the German company are Frank Hübler, Martin Black. | Agricultural Commodities/Milling | Chief Executive Officer | |
Cobepa SA
Cobepa SA Financial ConglomeratesFinance Cobepa SA is an investment holding Belgian company. The company is based in Brussels, Belgium. The company was founded in 1957. The CEO is Jean-Marie Laurent Josi. | Financial Conglomerates | Director/Board Member | |
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Boehringer Ingelheim Auslandsbeteiligungs GmbH MiscellaneousMiscellaneous Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim. | Miscellaneous | Chief Executive Officer | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The company is based in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal |
Estadísticas
Internacional
Alemania | 16 |
Francia | 5 |
Estados Unidos | 4 |
Suiza | 2 |
Suecia | 2 |
Sectorial
Health Technology | 13 |
Finance | 8 |
Commercial Services | 3 |
Process Industries | 3 |
Consumer Services | 2 |
Operativa
Chief Executive Officer | 18 |
Corporate Officer/Principal | 10 |
Director/Board Member | 7 |
Chairman | 2 |
President | 2 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Michael Schmelmer
- Conexiones Empresas